Loading…
Emotional functioning among children with neurofibromatosis type 1 or Noonan syndrome
While neurofibromatosis type 1 (NF1) and Noonan syndrome (NS) are clinically distinct genetic syndromes, they have overlapping features because they are caused by pathogenic variants in genes encoding molecules within the Ras‐mitogen‐activated protein kinase signaling pathway. Increased risk for emo...
Saved in:
Published in: | American journal of medical genetics. Part A 2019-12, Vol.179 (12), p.2433-2446 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3641-d0a211c76235ed5b0ec9252ae026f1aefaa5a26efce7a11705664906d08824ab3 |
---|---|
cites | cdi_FETCH-LOGICAL-c3641-d0a211c76235ed5b0ec9252ae026f1aefaa5a26efce7a11705664906d08824ab3 |
container_end_page | 2446 |
container_issue | 12 |
container_start_page | 2433 |
container_title | American journal of medical genetics. Part A |
container_volume | 179 |
creator | McNeill, Alana M. Hudock, Rebekah L. Foy, Allison M. H. Shanley, Ryan Semrud‐Clikeman, Margaret Pierpont, Mary Ella Berry, Susan A. Sommer, Katherine Moertel, Christopher L. Pierpont, Elizabeth I. |
description | While neurofibromatosis type 1 (NF1) and Noonan syndrome (NS) are clinically distinct genetic syndromes, they have overlapping features because they are caused by pathogenic variants in genes encoding molecules within the Ras‐mitogen‐activated protein kinase signaling pathway. Increased risk for emotional and behavioral challenges has been reported in both children and adults with these syndromes. The current study examined parent‐report and self‐report measures of emotional functioning among children with NF1 and NS as compared to their unaffected siblings. Parents and children with NS (n = 39), NF1 (n = 39), and their siblings without a genetic condition (n = 32) completed well‐validated clinical symptom rating scales. Results from parent questionnaires indicated greater symptomatology on scales measuring internalizing behaviors and symptoms of attention deficit hyperactivity disorder (ADHD) in both syndrome groups as compared with unaffected children. Frequency and severity of emotional and behavioral symptoms were remarkably similar across the two clinical groups. Symptoms of depression and anxiety were higher in children who were also rated as meeting symptom criteria for ADHD. While self‐report ratings by children generally correlated with parent ratings, symptom severity was less pronounced. Among unaffected siblings, parent ratings indicated higher than expected levels of anxiety. Study findings may assist with guiding family‐based interventions to address emotional challenges. |
doi_str_mv | 10.1002/ajmg.a.61361 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2299457688</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2313244136</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3641-d0a211c76235ed5b0ec9252ae026f1aefaa5a26efce7a11705664906d08824ab3</originalsourceid><addsrcrecordid>eNp9kD1PwzAQQC0E4ntjRpZYGGjxR-wkY4WggAosdLauyQVcJXGxE1X997i0dGBgsU_y05PvEXLB2ZAzJm5h3nwMYai51HyPHHOlxCDJpNzfzUIdkZMQ5oxJplJ9SI4kV1pneXpMpveN66xroaZV3xbr0bYfFBoXz-LT1qXHli5t90lb7L2r7My7BjoXbKDdaoGUU-fpq4uKloZVW8ZnPCMHFdQBz7f3KZk-3L_fPQ4mb-Onu9FkUEid8EHJQHBepFpIhaWaMSxyoQQgE7rigBWAAqGxKjAFzlMWf53kTJcsy0QCM3lKrjfehXdfPYbONDYUWNfQouuDESLPk7hylkX06g86d72Pe0dKcimSJAaM1M2GKrwLwWNlFt424FeGM7PObda5DZif3BG_3Er7WYPlDv7tG4FkAyxtjat_ZWb0_DIebbzfANeL_w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2313244136</pqid></control><display><type>article</type><title>Emotional functioning among children with neurofibromatosis type 1 or Noonan syndrome</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>McNeill, Alana M. ; Hudock, Rebekah L. ; Foy, Allison M. H. ; Shanley, Ryan ; Semrud‐Clikeman, Margaret ; Pierpont, Mary Ella ; Berry, Susan A. ; Sommer, Katherine ; Moertel, Christopher L. ; Pierpont, Elizabeth I.</creator><creatorcontrib>McNeill, Alana M. ; Hudock, Rebekah L. ; Foy, Allison M. H. ; Shanley, Ryan ; Semrud‐Clikeman, Margaret ; Pierpont, Mary Ella ; Berry, Susan A. ; Sommer, Katherine ; Moertel, Christopher L. ; Pierpont, Elizabeth I.</creatorcontrib><description>While neurofibromatosis type 1 (NF1) and Noonan syndrome (NS) are clinically distinct genetic syndromes, they have overlapping features because they are caused by pathogenic variants in genes encoding molecules within the Ras‐mitogen‐activated protein kinase signaling pathway. Increased risk for emotional and behavioral challenges has been reported in both children and adults with these syndromes. The current study examined parent‐report and self‐report measures of emotional functioning among children with NF1 and NS as compared to their unaffected siblings. Parents and children with NS (n = 39), NF1 (n = 39), and their siblings without a genetic condition (n = 32) completed well‐validated clinical symptom rating scales. Results from parent questionnaires indicated greater symptomatology on scales measuring internalizing behaviors and symptoms of attention deficit hyperactivity disorder (ADHD) in both syndrome groups as compared with unaffected children. Frequency and severity of emotional and behavioral symptoms were remarkably similar across the two clinical groups. Symptoms of depression and anxiety were higher in children who were also rated as meeting symptom criteria for ADHD. While self‐report ratings by children generally correlated with parent ratings, symptom severity was less pronounced. Among unaffected siblings, parent ratings indicated higher than expected levels of anxiety. Study findings may assist with guiding family‐based interventions to address emotional challenges.</description><identifier>ISSN: 1552-4825</identifier><identifier>EISSN: 1552-4833</identifier><identifier>DOI: 10.1002/ajmg.a.61361</identifier><identifier>PMID: 31566897</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>Anxiety ; Attention deficit hyperactivity disorder ; Children ; depression ; Emotional behavior ; emotional function ; Genetic disorders ; Kinases ; Neurofibromatosis ; neurofibromatosis type 1 ; Neurological disorders ; Noonan syndrome ; Noonan's syndrome ; Protein kinase ; RASopathies ; Recklinghausen's disease ; Siblings ; Signal transduction ; Tumors</subject><ispartof>American journal of medical genetics. Part A, 2019-12, Vol.179 (12), p.2433-2446</ispartof><rights>2019 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3641-d0a211c76235ed5b0ec9252ae026f1aefaa5a26efce7a11705664906d08824ab3</citedby><cites>FETCH-LOGICAL-c3641-d0a211c76235ed5b0ec9252ae026f1aefaa5a26efce7a11705664906d08824ab3</cites><orcidid>0000-0001-7555-8613 ; 0000-0002-9943-5236</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31566897$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McNeill, Alana M.</creatorcontrib><creatorcontrib>Hudock, Rebekah L.</creatorcontrib><creatorcontrib>Foy, Allison M. H.</creatorcontrib><creatorcontrib>Shanley, Ryan</creatorcontrib><creatorcontrib>Semrud‐Clikeman, Margaret</creatorcontrib><creatorcontrib>Pierpont, Mary Ella</creatorcontrib><creatorcontrib>Berry, Susan A.</creatorcontrib><creatorcontrib>Sommer, Katherine</creatorcontrib><creatorcontrib>Moertel, Christopher L.</creatorcontrib><creatorcontrib>Pierpont, Elizabeth I.</creatorcontrib><title>Emotional functioning among children with neurofibromatosis type 1 or Noonan syndrome</title><title>American journal of medical genetics. Part A</title><addtitle>Am J Med Genet A</addtitle><description>While neurofibromatosis type 1 (NF1) and Noonan syndrome (NS) are clinically distinct genetic syndromes, they have overlapping features because they are caused by pathogenic variants in genes encoding molecules within the Ras‐mitogen‐activated protein kinase signaling pathway. Increased risk for emotional and behavioral challenges has been reported in both children and adults with these syndromes. The current study examined parent‐report and self‐report measures of emotional functioning among children with NF1 and NS as compared to their unaffected siblings. Parents and children with NS (n = 39), NF1 (n = 39), and their siblings without a genetic condition (n = 32) completed well‐validated clinical symptom rating scales. Results from parent questionnaires indicated greater symptomatology on scales measuring internalizing behaviors and symptoms of attention deficit hyperactivity disorder (ADHD) in both syndrome groups as compared with unaffected children. Frequency and severity of emotional and behavioral symptoms were remarkably similar across the two clinical groups. Symptoms of depression and anxiety were higher in children who were also rated as meeting symptom criteria for ADHD. While self‐report ratings by children generally correlated with parent ratings, symptom severity was less pronounced. Among unaffected siblings, parent ratings indicated higher than expected levels of anxiety. Study findings may assist with guiding family‐based interventions to address emotional challenges.</description><subject>Anxiety</subject><subject>Attention deficit hyperactivity disorder</subject><subject>Children</subject><subject>depression</subject><subject>Emotional behavior</subject><subject>emotional function</subject><subject>Genetic disorders</subject><subject>Kinases</subject><subject>Neurofibromatosis</subject><subject>neurofibromatosis type 1</subject><subject>Neurological disorders</subject><subject>Noonan syndrome</subject><subject>Noonan's syndrome</subject><subject>Protein kinase</subject><subject>RASopathies</subject><subject>Recklinghausen's disease</subject><subject>Siblings</subject><subject>Signal transduction</subject><subject>Tumors</subject><issn>1552-4825</issn><issn>1552-4833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kD1PwzAQQC0E4ntjRpZYGGjxR-wkY4WggAosdLauyQVcJXGxE1X997i0dGBgsU_y05PvEXLB2ZAzJm5h3nwMYai51HyPHHOlxCDJpNzfzUIdkZMQ5oxJplJ9SI4kV1pneXpMpveN66xroaZV3xbr0bYfFBoXz-LT1qXHli5t90lb7L2r7My7BjoXbKDdaoGUU-fpq4uKloZVW8ZnPCMHFdQBz7f3KZk-3L_fPQ4mb-Onu9FkUEid8EHJQHBepFpIhaWaMSxyoQQgE7rigBWAAqGxKjAFzlMWf53kTJcsy0QCM3lKrjfehXdfPYbONDYUWNfQouuDESLPk7hylkX06g86d72Pe0dKcimSJAaM1M2GKrwLwWNlFt424FeGM7PObda5DZif3BG_3Er7WYPlDv7tG4FkAyxtjat_ZWb0_DIebbzfANeL_w</recordid><startdate>201912</startdate><enddate>201912</enddate><creator>McNeill, Alana M.</creator><creator>Hudock, Rebekah L.</creator><creator>Foy, Allison M. H.</creator><creator>Shanley, Ryan</creator><creator>Semrud‐Clikeman, Margaret</creator><creator>Pierpont, Mary Ella</creator><creator>Berry, Susan A.</creator><creator>Sommer, Katherine</creator><creator>Moertel, Christopher L.</creator><creator>Pierpont, Elizabeth I.</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7555-8613</orcidid><orcidid>https://orcid.org/0000-0002-9943-5236</orcidid></search><sort><creationdate>201912</creationdate><title>Emotional functioning among children with neurofibromatosis type 1 or Noonan syndrome</title><author>McNeill, Alana M. ; Hudock, Rebekah L. ; Foy, Allison M. H. ; Shanley, Ryan ; Semrud‐Clikeman, Margaret ; Pierpont, Mary Ella ; Berry, Susan A. ; Sommer, Katherine ; Moertel, Christopher L. ; Pierpont, Elizabeth I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3641-d0a211c76235ed5b0ec9252ae026f1aefaa5a26efce7a11705664906d08824ab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Anxiety</topic><topic>Attention deficit hyperactivity disorder</topic><topic>Children</topic><topic>depression</topic><topic>Emotional behavior</topic><topic>emotional function</topic><topic>Genetic disorders</topic><topic>Kinases</topic><topic>Neurofibromatosis</topic><topic>neurofibromatosis type 1</topic><topic>Neurological disorders</topic><topic>Noonan syndrome</topic><topic>Noonan's syndrome</topic><topic>Protein kinase</topic><topic>RASopathies</topic><topic>Recklinghausen's disease</topic><topic>Siblings</topic><topic>Signal transduction</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McNeill, Alana M.</creatorcontrib><creatorcontrib>Hudock, Rebekah L.</creatorcontrib><creatorcontrib>Foy, Allison M. H.</creatorcontrib><creatorcontrib>Shanley, Ryan</creatorcontrib><creatorcontrib>Semrud‐Clikeman, Margaret</creatorcontrib><creatorcontrib>Pierpont, Mary Ella</creatorcontrib><creatorcontrib>Berry, Susan A.</creatorcontrib><creatorcontrib>Sommer, Katherine</creatorcontrib><creatorcontrib>Moertel, Christopher L.</creatorcontrib><creatorcontrib>Pierpont, Elizabeth I.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of medical genetics. Part A</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McNeill, Alana M.</au><au>Hudock, Rebekah L.</au><au>Foy, Allison M. H.</au><au>Shanley, Ryan</au><au>Semrud‐Clikeman, Margaret</au><au>Pierpont, Mary Ella</au><au>Berry, Susan A.</au><au>Sommer, Katherine</au><au>Moertel, Christopher L.</au><au>Pierpont, Elizabeth I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Emotional functioning among children with neurofibromatosis type 1 or Noonan syndrome</atitle><jtitle>American journal of medical genetics. Part A</jtitle><addtitle>Am J Med Genet A</addtitle><date>2019-12</date><risdate>2019</risdate><volume>179</volume><issue>12</issue><spage>2433</spage><epage>2446</epage><pages>2433-2446</pages><issn>1552-4825</issn><eissn>1552-4833</eissn><abstract>While neurofibromatosis type 1 (NF1) and Noonan syndrome (NS) are clinically distinct genetic syndromes, they have overlapping features because they are caused by pathogenic variants in genes encoding molecules within the Ras‐mitogen‐activated protein kinase signaling pathway. Increased risk for emotional and behavioral challenges has been reported in both children and adults with these syndromes. The current study examined parent‐report and self‐report measures of emotional functioning among children with NF1 and NS as compared to their unaffected siblings. Parents and children with NS (n = 39), NF1 (n = 39), and their siblings without a genetic condition (n = 32) completed well‐validated clinical symptom rating scales. Results from parent questionnaires indicated greater symptomatology on scales measuring internalizing behaviors and symptoms of attention deficit hyperactivity disorder (ADHD) in both syndrome groups as compared with unaffected children. Frequency and severity of emotional and behavioral symptoms were remarkably similar across the two clinical groups. Symptoms of depression and anxiety were higher in children who were also rated as meeting symptom criteria for ADHD. While self‐report ratings by children generally correlated with parent ratings, symptom severity was less pronounced. Among unaffected siblings, parent ratings indicated higher than expected levels of anxiety. Study findings may assist with guiding family‐based interventions to address emotional challenges.</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>31566897</pmid><doi>10.1002/ajmg.a.61361</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0001-7555-8613</orcidid><orcidid>https://orcid.org/0000-0002-9943-5236</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1552-4825 |
ispartof | American journal of medical genetics. Part A, 2019-12, Vol.179 (12), p.2433-2446 |
issn | 1552-4825 1552-4833 |
language | eng |
recordid | cdi_proquest_miscellaneous_2299457688 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Anxiety Attention deficit hyperactivity disorder Children depression Emotional behavior emotional function Genetic disorders Kinases Neurofibromatosis neurofibromatosis type 1 Neurological disorders Noonan syndrome Noonan's syndrome Protein kinase RASopathies Recklinghausen's disease Siblings Signal transduction Tumors |
title | Emotional functioning among children with neurofibromatosis type 1 or Noonan syndrome |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T00%3A21%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Emotional%20functioning%20among%20children%20with%20neurofibromatosis%20type%201%20or%20Noonan%20syndrome&rft.jtitle=American%20journal%20of%20medical%20genetics.%20Part%20A&rft.au=McNeill,%20Alana%20M.&rft.date=2019-12&rft.volume=179&rft.issue=12&rft.spage=2433&rft.epage=2446&rft.pages=2433-2446&rft.issn=1552-4825&rft.eissn=1552-4833&rft_id=info:doi/10.1002/ajmg.a.61361&rft_dat=%3Cproquest_cross%3E2313244136%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3641-d0a211c76235ed5b0ec9252ae026f1aefaa5a26efce7a11705664906d08824ab3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2313244136&rft_id=info:pmid/31566897&rfr_iscdi=true |